WELCOME
Stellar Biotechnologies has successfully developed, optimized and demonstrated the first dedicated aquaculture technologies and non-lethal hemocyanin extraction methods for commercial scale production of keyhole limpet hemocyanin (KLH) from Megathura crenulata (the giant keyhole limpet) for biomedical applications.
Read more
KLH AS AN IMMUNE RESPONSE MODIFIER
KLH is a safe and flexible antigen platform for the preparation of potent immune conjugates from a wide variety of candidate antigen molecules.
KLH is a high molecular respiratory glycoprotein from the hemolymph of the marine mollusc Megathura crenulata. The protein is expressed in two subunit isoforms (KLH1 and KLH2) of ~360-390 kD monomeric molecular weight; both isoforms assemble into native homo-didecamers of ~8,000 kD in hemolymph.
Read more
ABOUT US
Stellar Biotechnologies, Inc. is a California-based biological product company specializing in the production of GMP-grade KLH (keyhole limpet hemocyanin) protein products for biomedical applications. Stellar's KLH products are derived from the hemolymph of aquacultured animals that are raised using proprietary methods in our controlled-environment cultivation systems. Stellar has a history of successful implementation of Federal NIH grant funded research to advance its technology and commercialize its products. We manufacture GMP-grade supplies of this critical component for a new class of medicines known as therapeutic vaccines that are being used to treat cancer, hypertension, arthritis, drug addiction and other serious chronic diseases.
Read more
FACILITIES
Our facilities include a state-of-the-art controlled aquaculture systems for animal cultivation and manufacturing facilities for cGMP KLH production.